Lataa...
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
BACKGROUND: Alzheimer’s disease (AD) is characterized by physiologically endogenous proteins amyloid beta (Aβ) and tau undergoing a conformational change and accumulating as soluble oligomers and insoluble aggregates. Tau and Aβ soluble oligomers, which contain extensive β-sheet secondary structure,...
Tallennettuna:
| Julkaisussa: | Alzheimers Res Ther |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006698/ https://ncbi.nlm.nih.gov/pubmed/29914551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0384-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|